Literature DB >> 12629416

The ameliorating effect of melatonin on protamine sulfate induced bladder injury and its relationship to interstitial cystitis.

Sule Cetinel1, Feriha Ercan, Serap Sirvanci, Ozer Sehirli, Yasemin Ersoy, Tangül San, Göksel Sener.   

Abstract

PURPOSE: The pineal hormone melatonin was recently shown to have free radical scavenging ability and it reduces lipid peroxidation. In this morphological study we investigated the effects of melatonin on protamine sulfate (Sigma Chemical Co., St. Louis, Missouri) induced bladder injury.
MATERIALS AND METHODS: Albino Wistar female rats were catheterized and intravesically infused with phosphate buffered solution (control group) or protamine sulfate (bladder injury group) dissolved in phosphate buffered solution. In the protamine sulfate plus melatonin group after protamine sulfate instillation melatonin was injected intraperitoneally. Bladder morphology was investigated by light and electron microscopy. Tissue samples were also obtained to determine bladder malondialdehyde levels.
RESULTS: In the bladder injury group ulcerated areas, an irregular glycosaminoglycan layer, increased number of mast cells, vacuole formation, dilated perinuclear cistern, formation of pleomorphic and uniform microvilli, and dilated urothelial intercellular spaces were observed. In the bladder injury plus melatonin group a relatively normal urothelial topography, glycosaminoglycan layer and decreased number of mucosal mast cells, some dilatation between intercellular areas, less uniform microvilli and in most areas regular tight junctions were observed.
CONCLUSIONS: Increased malondialdehyde levels as a result of protamine sulfate induction lead us to propose that free radicals may have a critical role in this injury. The significant decrease in malondialdehyde levels in the protamine sulfate plus melatonin group was in accordance with morphological findings. Thus, melatonin appears to exert a urothelial protective activity in a bladder injury model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629416     DOI: 10.1097/01.ju.0000049649.80549.17

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

2.  Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: response to a standardized grape suspension.

Authors:  Alpha Dian-Yu Lin; Anita Mannikarottu; Barry A Kogan; Catherine Whitbeck; Robert E Leggett; Robert M Levin
Journal:  Mol Cell Biochem       Date:  2007-01-03       Impact factor: 3.396

3.  Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

Authors:  Pradeep Tyagi; Mahendra Kashyap; Naoki Yoshimura; Michael Chancellor; Christopher J Chermansky
Journal:  J Urol       Date:  2016-11-18       Impact factor: 7.450

Review 4.  The effect of amino acids on the bladder cycle: a concise review.

Authors:  Özer Ural Çakıcı; Sibel Dinçer
Journal:  Amino Acids       Date:  2021-12-01       Impact factor: 3.520

5.  Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder.

Authors:  Yung-Shun Juan; Tasmina Hydery; Anita Mannikarottu; Barry Kogan; Catherine Schuler; Robert E Leggett; Wei-Yu Lin; Chun-Hsiung Huang; Robert M Levin
Journal:  Mol Cell Biochem       Date:  2007-12-30       Impact factor: 3.396

6.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

7.  Indirect autonomic nervous system activity assessment with heart rate variability in rats with cyclophosphamide-induced hemorrhagic cystitis treated with melatonin or agomelatine.

Authors:  Łukasz Dobrek; Agnieszka Baranowska; Piotr J Thor
Journal:  Contemp Oncol (Pozn)       Date:  2015-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.